Evaluation of Alternate-Day Buprenorphine Blockade

This study focuses on evaluating the effectiveness of a medication called buprenorphine in managing opioid dependence. The goal is to understand how well this treatment works in blocking the effects of opioids, potentially helping those struggling with opioid addiction. The study is in its early stages, known as Phase 1, and is conducted with a treatment purpose. Participants in this study will undergo a 'buprenorphine blockade challenge'. This involves taking buprenorphine and then observing various responses. These include changes in drug use, opioid withdrawal symptoms, and physical changes like blood pressure, heart rate, pupil diameter, and respiration. The study also measures buprenorphine levels in the blood and asks participants to estimate their subjective dose. This helps researchers understand the drug's characteristics and effects.